We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Pastimesvitamins herbs supplements longevity and aging

Previous 10 Next 10 
To: John Vosilla who wrote (16191)7/29/2022 9:56:47 PM
From: Pogeu Mahone
   of 16225
Old skin does not convert sunlight to D3
Older adults, because your skin doesn't make vitamin D when exposed to sunlight as efficiently as when you were young, and your kidneys are less able to convert vitamin D to its active form. People with dark skin, which has less ability to produce vitamin D from the sun.Feb 28, 2017

You are too old so supplement your D3;000)))

I ran 60000 miles
I did not do it at night.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: Pogeu Mahone who wrote (16192)8/4/2022 6:00:42 PM
From: John Vosilla
2 Recommendations   of 16225
8 Health Benefits of Getting Back to Nature and Spending Time Outside

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: John Vosilla who wrote (16193)8/6/2022 9:05:13 AM
From: gg cox
   of 16225
Mushrooms and vitamin D

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

From: Thomas M.8/6/2022 10:40:09 AM
   of 16225
In the 1960s John Lykoudis successfully treated 10,000 patients with peptic ulcer using antibiotics. He was fined by medical authorities, indicted in court, and unable to get an article published in medical journals.

Ulcers were a cash cow for gastroenterologists and surgeons. The Mayo Clinic for example was built on gastric surgery.

John Lykoudis: an unappreciated discoverer of the cause and treatment of peptic ulcer disease


Share RecommendKeepReplyMark as Last Read

To: gg cox who wrote (16194)8/6/2022 10:43:48 AM
From: Neeka
   of 16225
I was really looking forward to reading that article.

Check out your link.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: Neeka who wrote (16196)8/6/2022 2:28:08 PM
From: gg cox
   of 16225
Oops,, here it is.

Lots of chanterelles out this year around here how are you doin?

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

To: gg cox who wrote (16197)8/6/2022 2:55:51 PM
From: Neeka
   of 16225
Surprisingly, even sliced and dried mushrooms—including wild ones picked the year before—will soar in vitamin D when placed outdoors under the sun.

This I did not know. Always thought the mushrooms had to be fresh and raw to absorb vit D from sunshine. I have several jars of sliced, dried mushrooms and also powder. I will set them out on a tray for 6 hours a day for two days, so I can increase the amount of vitamin D in them.

Doing very well (thanks for asking) and looking forward to the Fall mushroom hunt. First off in the Fall we go high up into the mts and harvest Kings and Hedgehogs. We usually wait for the first Sept rains, and then we go to a lower elevation for the white and golden chanterelles around the same time period. We go even lower for the Fall and Spring oyster mushrooms.

Have fun! ;)

Share RecommendKeepReplyMark as Last ReadRead Replies (1)

From: Pogeu Mahone8/8/2022 9:23:22 AM
1 Recommendation   of 16225
San Francisco Kink & Fetish Festival to Press On Despite Monkeypox Emergency Declaration

[Suppressed Image]

The government barred us from saying goodbye to loved ones in nursing homes and hospitals during the Covid pandemic.

The government didn’t allow us to have funerals for loved ones during the Covid pandemic.

But the kink and fetish festival for gay men dubbed “Up Your Alley” is a go this weekend despite monkeypox spreading like wildfire in the gay community in San Francisco.

Per CDC, monkeypox is transmitted by symptomatic individuals through close contact with lesions, bodily fluids, or respiratory secretions and objects that have had contact with lesion crusts or bodily fluids, face-to-face contact, or during intimate physical contact, such as kissing, cuddling, or sex.

[Suppressed Image]

“Up Your Alley® is only for real players – and not for the faint of heart – where leather daddies rule the streets of San Francisco’s South of Market district. Of course, if rubber, sportswear, biker gear, skinheads, punks, or any variety of built, hairy men turns you on, then we’ve got it. You won’t find a filthier event in the States. If you’re into it, there’s a scene for you. So, don’t get left out.” a site promoting the event said.

“Located in front of the legendary Powerhouse bar, nearly 15,000 fellow leather men and fetish enthusiasts engage in BDSM play at over 50 adult vendor spaces! Spanking, punching, whips and floggers, bondage, domination and submission, creative watersports, toys and so much more are in full effect.” the site said.

San Francisco on Thursday declared a state of emergency over monkeypox.

The mayor of San Francisco declared a state of emergency after the city reported 261 cases of monkeypox.

The emergency declaration will take effect on Monday.

The Up Your Alley street fair is referred to as the “little broth to the Folsom Street Fair” which is scheduled for later this year.

The Folsom Festival scheduled for September 22 is also pressing on despite San Francisco declaring a state of emergency over monkeypox.

Last year 40,000 freaks attended the Folsom Festival after a two-year delay because of Covid.

“I’d describe it as a raunchy, inclusive festival to celebrate kink and leather,” one of the festival attendees told ABC 7 last year.

[Suppressed Image]

video on the website:

Share RecommendKeepReplyMark as Last Read

From: Pogeu Mahone8/10/2022 10:01:03 PM
   of 16225
Health Care
Medical Mysteries

New Langya virus that may have spilled over from animals infects dozens

By Amy Cheng

August 10, 2022 at 4:59 a.m. EDT

Share RecommendKeepReplyMark as Last Read

From: Pogeu Mahone8/11/2022 11:41:43 AM
   of 16225
Urology> General Urology

Removing Small Asymptomatic Kidney Stones Significantly Reduces Recurrence— Two-year difference in time to relapse, study showedby Charles Bankhead, Senior Editor, MedPage Today August 10, 2022

Removing small, asymptomatic kidney stones during endoscopic removal of ureteral or contralateral stones significantly prolonged the time to relapse as compared with leaving the asymptomatic stones behind, a randomized trial showed.

The time to relapse averaged about 4.5 years with removal of asymptomatic stones versus about 2.5 years without (P<0.001). The difference represented an 82% reduction in the hazard ratio for relapse. In absolute terms, relapse occurred in 16% of patients with treated asymptomatic stones as compared with 63% of patients in the control arm.

When stone growth rate was excluded in sensitivity analysis, the relapse rate remained significantly higher in the control group. Surgery-related emergency department (ED) visits were similar between the two groups, reported Michael R. Bailey, PhD, of the University of Washington in Seattle, and co-authors, in the New England Journal of Medicine.

"Results of our prospective, randomized trial support removal of small, asymptomatic renal stones at the time of surgery to remove a symptomatic stone," the authors said of their findings. "Whether to remove small asymptomatic kidney stones is a common surgical decision that currently lacks specific guidelines and may involve hundreds of thousands of surgeries annually in the U.S. alone. The additional 25 minutes needed to remove small, asymptomatic renal stones at the time of surgery for a primary stone ... should be weighed against the potential need for repeat surgery in the 63% of patients who had a relapse."

One financial comparison showed that 25 additional minutes of surgery at $36/minute would add $90,000 to the cost of 100 surgeries, the authors noted. On the other hand, 63 emergency department visits would have an estimated cost of $217,000.

The results are not surprising but the trial was nonetheless worthwhile, according to the author of an accompanying editorial. Modern endourologic technology and techniques in the hands of experienced endourologists facilitated the trial's success, said David S. Goldfarb, MD, of the New York Harbor Veterans Affairs Healthcare System and NYU Langone Health in New York City.

The trial results left several questions unanswered. Can the preventive strategy be applied equitably to most patients with asymptomatic stones? Can general urologists also perform the procedure with the same results? Would the number of asymptomatic stones affect the results? Would increased use of preventive medication (only 25% in this study) have changed the results?

"Finally, and most provocatively, when should asymptomatic stones be removed endoscopically -- only when a primary obstructing ureteral stone or a large, asymptomatic stone in the kidney is present, as this protocol dictated?" Goldfarb asked. "Asymptomatic stones are identified frequently and, most often, surgery is not recommended."

"One can imagine that elective removal may allow these patients to avoid pain and trauma, inefficient and costly emergency department visits, infections, receipt of pain medications, and additional imaging studies," he added. "An alternative to preemptive surgical intervention would be to finally figure out how to make those small stones detach and pass spontaneously."

The prospective, multicenter study addressed the longstanding question of whether endoscopic removal of small asymptomatic kidney stones at the time of surgery for a symptomatic stone would is beneficial. Relevant U.S. and European clinical guidelines equivocate on the issue, Bailey and co-authors stated.

Multiple studies have shown that patients with asymptomatic stones have a 50% chance of recurrence within 5 years of surgery for a symptomatic stone. However, the only prospective study cited by guideline authors evaluated shock-wave lithotripsy for treating asymptomatic stones and favored observation at 1 year.

In an effort to provide prospective data to inform decision-making, investigators enrolled 75 adult patients scheduled to undergo endoscopic surgery (ureteroscopy or percutaneous nephrolithotomy) for a primary stone. The patients randomized to removal of secondary (asymptomatic) stones by ureteroscopy or observation (control group). Postoperative CT was performed 90 days and 1 year after intervention.

Patients were followed at 3-month intervals for up to 5 years. Median follow-up duration was 4.2 years. The primary outcome was the composite of ED visits related to stones on the same side as the original surgery, subsequent surgery to remove stones on the trial side, or growth of a new secondary stone. Secondary outcomes included surgical time to remove asymptomatic stones, ED visits within 2 weeks of surgery, and patient-reported stone passage or new stone growth.

All but two patients were included in the analysis of primary and secondary outcomes. The data showed that relapse occurred in six of 38 patients in the treatment arm versus 22 of 35 patients in the control group. The absolute difference of 47 percentage points exceeded the 35 percentage points used for statistical power calculations.

After excluding stone growth as a marker of relapse, the median time to relapse remained significantly prolonged in the treatment arm (1,717.1 vs 1,262.8 days). Four patients (11%) in the treatment group and 15 (43%) in the control arm had ED visits or additional surgery.

The 25.6 minutes of additional surgical time required for asymptomatic stone removal accounted for 27% of total surgery time (93.6 vs 59.8 minutes in the control group). Additional time with ureteroscopy averaged 25.0 minutes and 30 minutes with percutaneous nephrolithotomy.

Eight patients in the treatment arm and 10 in the control arm reported stone passage. Seven in the treatment group and six in the control arm reported passages of asymptomatic stones or fragments. New stone formation occurred in 14 patients in the treatment arm (average time 1,338 days to treatment) versus 13 in the control arm (1,381 days).

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10